Topic

Articles

The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.

Sanofi Acquires Biogen's Bioverativ

Merck & Co. has acquired oncology-focused biopharmaceutical company Viralytics to strengthen Merck's oncology pipeline.

Merck & Co. Acquires Viralytics for $394 Million

Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.

Roche to Acquire Flatiron Health for $1.9 Billion

The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.

V ClinBio Acquires Cellix to Gain Patented Drug Delivery Technology

Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.

Avista Pharma Acquires Solid Form Solutions

The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.

Sanofi to Acquire Ablynx in $4.8-Billion Deal

The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.

AGC Biologics, Biomeva, CMC Biologics Combine

Meissner Filtration Products has acquired PDC Aseptic Filling Systems, a supplier of aseptic filling systems and sealers, to expand Meissner's automated platform offerings.

Meissner Acquires PDC Aseptic Filling Systems

KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.

KBI Biopharma Acquires Elion Labs

The acquisition would boost Sanofi's position in hematology and specialty medicines.

Mergers and Acquisitions